| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872054 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 5 Pages |
Abstract
Conclusion: Prophylactic cranial irradiation may reduce the incidence of brain metastases, but there is no evidence of a survival benefit. It was not possible to evaluate whether any radiotherapy regimen is superior, and the effect of PCI on quality of life is not known. There is insufficient evidence to support the use of PCI in clinical practice. Where possible, patients should be offered entry into a clinical trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jason Francis (F.R.C.R.), Fergus R. (F.R.C.R.), Bernadette Coles,